Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 11/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.44 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.44 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.44 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.42 |
| ▸ | LY96 | Q9Y6Y9 | 6/20 | 0.40 |
| ▸ | CD69 | Q07108 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22524789 | 1.00 | TLR4 (0.49) | TLR4MAPK1LGALS3LGALS8LGALS4 | |
| SCHEMBL19220668 | 1.00 | TLR4 (0.49) | TLR4MAPK1LGALS3LGALS8LGALS4 | |
| SCHEMBL19225338 | 1.00 | TLR4 (0.49) | TLR4MAPK1LGALS3LGALS8LGALS4 | |
| SCHEMBL20685511 | 0.94 | TLR4 (0.44) | TLR4MAPK1LGALS3LGALS8LGALS4 | |
| SCHEMBL21565161 | 0.94 | TLR4 (0.44) | TLR4MAPK1LGALS3LGALS8LGALS4 | |
| SCHEMBL22617797 | 0.94 | TLR4 (0.44) | TLR4MAPK1LGALS3LGALS8LGALS4 | |
| SCHEMBL19225477 | 0.94 | TLR4 (0.44) | TLR4MAPK1LGALS3LGALS8LGALS4 | |
| SCHEMBL19220669 | 0.94 | TLR4 (0.44) | TLR4MAPK1LGALS3LGALS8LGALS4 | |
| SCHEMBL19225475 | 0.94 | TLR4 (0.44) | TLR4MAPK1LGALS3LGALS8LGALS4 | |
| SCHEMBL19225429 | 0.94 | TLR4 (0.44) | TLR4MAPK1LGALS3LGALS8LGALS4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11716994-B2 | Combinations of Yersinia entomophaga and pesticides or other substances | NOVOZYMES BIOAG A/S (DK) | 2023-08-08 | — | — | US | disclosed |
| US-11560342-B2 | Bacillus isolates and uses thereof | MONSANTO TECHNOLOGY, LLC (US) | 2023-01-24 | — | — | US | disclosed |
| US-20230009728-A1 | LIPO-CHITOOLIGOSACCHARIDE COMPOSITIONS FOR ENHANCING PLANT GROWTH | NOVOZYMES BIOAG A/S (DK) | 2023-01-12 | — | — | US | disclosed |
| US-20210068401-A1 | BACILLUS ISOLATES AND USES THEREOF | MONSANTO TECHNOLOGY LLC (US) | 2021-03-11 | — | — | US | disclosed |
| US-20200375179-A1 | AQUEOUS COMPOSITIONS COMPRISING SOLUBILZED LIPO-CHITOOLIGOSACCHARIDES | NOVOZYMES BIOAG A/S (DK) | 2020-12-03 | — | — | US | disclosed |
| US-20200323198-A1 | STABLE LIQUID INOCULANT COMPOSITIONS AND COATED PLANT PROPAGATION MATERIALS COMPRISING SAME | NOVOZYMES A/S (DK) | 2020-10-15 | — | — | US | disclosed |
| US-20200138041-A1 | STABLE INOCULANT COMPOSITIONS COMPRISING METHYLATED PLANT OILS | NOVOZYMES BIOAG A/S (DK) | 2020-05-07 | — | — | US | disclosed |
| US-20200085065-A1 | STABLE INOCULANT COMPOSITIONS AND METHODS FOR PRODUCING SAME | NOVOZYMES BIOAG A/S (DK) | 2020-03-19 | — | — | US | disclosed |
| US-20200060284-A1 | Combinations of Yersinia entomophaga and Pesticides or Other Substances | NOVOZYMES BIOAG A/S (DK) | 2020-02-27 | — | — | US | disclosed |
| US-20190029262-A1 | Stable Inoculant Compositions and Methods for Producing Same | NOVOZYMES BIOAG A/S (DK) | 2019-01-31 | — | — | US | disclosed |
| US-20180201549-A1 | USE OF FUNGAL STRAINS TO SOLUBILIZE PHOSPHATE AND ENHANCE PLANT GROWTH/YIELD | NOVOZYMES BIOAG A/S (DK) | 2018-07-19 | — | — | US | disclosed |
| US-20170223956-A1 | LIPO-CHITOOLIGOSACCHARIDE COMPOSITIONS FOR ENHANCING PLANT GROWTH | NOVOZYMES BIOAG A/S (DK) | 2017-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190029262-A1 | Stable Inoculant Compositions and Methods for Producing Same | MGAM, MGAM2, MRPL21 | TLR4 1136/4885MAPK1 2131/4885LGALS3 440/4885 |
| US-20210068401-A1 | BACILLUS ISOLATES AND USES THEREOF | BLVRB, BROX, GLB1 | TLR4 770/4885MAPK1 3187/4885LGALS3 2100/4885 |
| US-20200323198-A1 | STABLE LIQUID INOCULANT COMPOSITIONS AND COATED PLANT PROPAGATION MATERIALS COMPRISING SAME | PNMT, AMPD2, MTAP | TLR4 1677/4885MAPK1 2363/4885LGALS3 4241/4885 |
| US-11716994-B2 | Combinations of Yersinia entomophaga and pesticides or other substances | TRHDE, MLNR, DDT | TLR4 624/4885MAPK1 1432/4885LGALS3 1841/4885 |
| US-20200375179-A1 | AQUEOUS COMPOSITIONS COMPRISING SOLUBILZED LIPO-CHITOOLIGOSACCHARIDES | DDOST, STT3B, LCT | TLR4 596/4885MAPK1 3827/4885LGALS3 87/4885 |
| US-11560342-B2 | Bacillus isolates and uses thereof | BLVRB, BROX, GLB1 | TLR4 770/4885MAPK1 3187/4885LGALS3 2100/4885 |
| US-20230009728-A1 | LIPO-CHITOOLIGOSACCHARIDE COMPOSITIONS FOR ENHANCING PLANT GROWTH | CHIT1, LPO, DDOST | TLR4 665/4885MAPK1 3380/4885LGALS3 157/4885 |
| US-20200138041-A1 | STABLE INOCULANT COMPOSITIONS COMPRISING METHYLATED PLANT OILS | DNMT1, ALKBH5, MTAP | TLR4 1166/4885MAPK1 3612/4885LGALS3 3905/4885 |
| US-20200060284-A1 | Combinations of Yersinia entomophaga and Pesticides or Other Substances | TRHDE, MLNR, DDT | TLR4 624/4885MAPK1 1432/4885LGALS3 1841/4885 |
| US-20200085065-A1 | STABLE INOCULANT COMPOSITIONS AND METHODS FOR PRODUCING SAME | UGDH, SORD, MGAM | TLR4 299/4885MAPK1 2879/4885LGALS3 377/4885 |
| US-20170223956-A1 | LIPO-CHITOOLIGOSACCHARIDE COMPOSITIONS FOR ENHANCING PLANT GROWTH | CHIT1, LPO, DDOST | TLR4 911/4885MAPK1 4270/4885LGALS3 180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.